South Texas Accelerated Research Therapeutics (START) - Midwest — Grand Rapids, Michigan

South Texas Accelerated Research Therapeutics (START) - Midwest is a clinical research site located in Grand Rapids, Michigan, United States 49546.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

South Texas Accelerated Research Therapeutics (START) - Midwest has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Solid Tumor, Metastatic Solid Tumor.

Sponsors: Artios Pharma Ltd.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for South Texas Accelerated Research Therapeutics (START) - Midwest?

South Texas Accelerated Research Therapeutics (START) - Midwest has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has South Texas Accelerated Research Therapeutics (START) - Midwest conducted?

South Texas Accelerated Research Therapeutics (START) - Midwest has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Solid Tumor, Metastatic Solid Tumor.

Is South Texas Accelerated Research Therapeutics (START) - Midwest accredited by Crixeo Health?

South Texas Accelerated Research Therapeutics (START) - Midwest has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about South Texas Accelerated Research Therapeutics (START) - Midwest?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.